Literature DB >> 25168547

Complications associated with photoselective vaporization of the prostate: categorization by a panel of GreenLight users according to Clavien score and report of a single-center experience.

Benoit Peyronnet1, Benjamin Pradere2, Nicolas Brichart2, Thomas Bodin2, Philippe Bertrand3, Franck Bruyère4.   

Abstract

OBJECTIVE: To devise and validate a system to categorize GreenLight photoselective vaporization of prostate (PVP) complications according to Clavien score (CS), to report complications of PVP using this categorization, and to determine risk factors.
MATERIALS AND METHODS: A survey questionnaire was distributed to all participants of the second meeting of the Group of GreenLight Users. They were asked to grade PVP complications according to CS. We calculated the mode CS for each complication from the survey data to propose a categorization system for complications of PVP. Complications encountered in a large single-center cohort of 370 patients were reported according to this system. We assessed the reproducibility of CS by estimating inter-rater agreement by the Fleiss kappa. We performed univariate and multivariate analyses to determine risk factors for complications.
RESULTS: Of the 67 meeting participants, 42 (62.7%) completed the survey. Overall agreement between urologists was fair (Fleiss kappa = 0.356). Among the 370 patients, 21 (5.7%) had intraoperative complications, 147 (39.7%) had postoperative complications, and 70 (18.9%) had long-term complications. Among the postoperative complications, 125 patients (33.8%) were classified as Clavien grade I, 58 (15.7%) as Clavien grade II, 4 (1.1%) as Clavien grade IIIb, 5 (1.3%) as Clavien grade IVa, 1 (0.3%) as Clavien grade IVb, and 1 (0.3%) as Clavien grade V. In multivariate analysis, the only predictor of overall complications was a polymicrobial preoperative urine culture.
CONCLUSION: The grading of PVP complications by CS is fairly reproducible. We are the first to propose a system for the categorization of PVP complications. PVP complications are frequent but most often minor.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25168547     DOI: 10.1016/j.urology.2014.05.028

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Monopolar enucleation versus transurethral resection of the prostate for small- and medium-sized (< 80 cc) benign prostate hyperplasia: a prospective analysis.

Authors:  Dmitry Enikeev; Leonid Rapoport; Magomed Gazimiev; Sergey Allenov; Jasur Inoyatov; Mark Taratkin; Ekaterina Laukhtina; John M Sung; Zhamshid Okhunov; Petr Glybochko
Journal:  World J Urol       Date:  2019-04-08       Impact factor: 4.226

2.  Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser.

Authors:  Xin Wang; Yao-Guang Zhang; Sheng-Cai Zhu; Ben Wan; Ming Liu; Jian-Ye Wang
Journal:  J Vis Exp       Date:  2018-05-09       Impact factor: 1.355

3.  Photoselective vaporization of the prostate with the 180-W XPS-Greenlight laser: Five-year experience of safety, efficiency, and functional outcomes.

Authors:  Khaled Ajib; Mila Mansour; Marc Zanaty; Mansour Alnazari; Pierre-Alain Hueber; Malek Meskawi; Roger Valdivieso; Come Tholomier; Benjamin Pradere; Vincent Misrai; Dean Elterman; Kevin C Zorn
Journal:  Can Urol Assoc J       Date:  2018-03-19       Impact factor: 1.862

4.  Photoselective Vaporesection of the Prostate with an End-firing Lithium Triborate Crystal Laser.

Authors:  Xin Wang; Ming Liu; Yao-Guang Zhang; Sheng-Cai Zhu; Ben Wan; Jian-Ye Wang
Journal:  Chin Med J (Engl)       Date:  2017-03-20       Impact factor: 2.628

5.  Efficacy and safety of transurethral split of prostate for benign prostatic hyperplasia: a meta-analysis.

Authors:  Yiyu Huang; Jiaxin Li; Shan Yang; Daozhang Yuan; Shusheng Wang
Journal:  BMC Urol       Date:  2020-09-03       Impact factor: 2.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.